MANNKIND CORP — Director's Dealing 2019

Feb 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2019-01-31

Reporting Person: Kendall David M (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-31	Common Stock, $0.01 Par Value	P	5000	$1.07	Acquired	7824	Direct

Footnotes

F1: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2019 representing the maximum allowable under the Plan for this period.